ArticleInternational journal of general medicine2013

Inhibition of the early asthmatic response to inhaled allergen by the 5-lipoxygenase activating protein inhibitor GSK2190915: a dose-response study.

Dave Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.